Bleakley Financial Group, LLC Amarin Corp Plcuk Transaction History
Bleakley Financial Group, LLC
- $3.12 Trillion
- Q1 2025
A detailed history of Bleakley Financial Group, LLC transactions in Amarin Corp Plcuk stock. As of the latest transaction made, Bleakley Financial Group, LLC holds 468,848 shares of AMRN stock, worth $7.37 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
468,848
Previous 468,848
-0.0%
Holding current value
$7.37 Million
Previous $227 Million
7.61%
% of portfolio
0.01%
Previous 0.01%
Shares
4 transactions
Others Institutions Holding AMRN
# of Institutions
154Shares Held
70.1MCall Options Held
133KPut Options Held
26.4K-
Sarissa Capital Management LP Greenwich, CT24.9MShares$390 Million60.8% of portfolio
-
Kynam Capital Management, LP Princeton, NJ12.4MShares$195 Million9.37% of portfolio
-
Acadian Asset Management LLC Boston, MA3.79MShares$59.6 Million0.0% of portfolio
-
Eversept Partners, LP New York, NY3.4MShares$53.4 Million3.37% of portfolio
-
Morgan Stanley New York, NY2.62MShares$41.2 Million0.0% of portfolio
About AMARIN CORP PLCUK
- Ticker AMRN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 403,206,016
- Market Cap $6.33B
- Description
- Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, Germany, Canada, Lebanon, and the United Arab Emirates. Its lead product is VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for r...